APA (7th ed.) Citation

Papp, K. A., Armstrong, A. W., Koresawa, T., Otake, K., Hirata, M., & Kano, A. (2026). Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis. Journal of the European Academy of Dermatology & Venereology, 40(4), 610. https://doi.org/10.1111/jdv.20863

Chicago Style (17th ed.) Citation

Papp, Kim A., April W. Armstrong, Tomokazu Koresawa, Kazunari Otake, Masayuki Hirata, and Akiko Kano. "Efficacy and Safety of ME3183, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Plaque Psoriasis." Journal of the European Academy of Dermatology & Venereology 40, no. 4 (2026): 610. https://doi.org/10.1111/jdv.20863.

MLA (9th ed.) Citation

Papp, Kim A., et al. "Efficacy and Safety of ME3183, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Plaque Psoriasis." Journal of the European Academy of Dermatology & Venereology, vol. 40, no. 4, 2026, p. 610, https://doi.org/10.1111/jdv.20863.